A longitudinal analysis with CA-125 to predict overall survival in patients with ovarian cancer
Open Access
- 1 January 2014
- journal article
- Published by Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy in Journal of Gynecologic Oncology
- Vol. 25 (1), 51-57
- https://doi.org/10.3802/jgo.2014.25.1.51
Abstract
Chiang AJ, et al. J Gynecol Oncol. 2014 Jan;25(1):51-57. https://doi.org/10.3802/jgo.2014.25.1.51Keywords
Funding Information
- KSVGH (VGHKS 101-120)
- National Science Council of Taiwan (NSC 101-2118-M-110-004)
This publication has 28 references indexed in Scilit:
- Prognostic Value of Residual Tumor Size in Patients With Epithelial Ovarian Cancer FIGO Stages IIA–IV: Analysis of the OVCAD DataInternational Journal of Gynecologic Cancer, 2012
- Protein Biomarkers of Ovarian Cancer: The Forest and The TreesFuture Oncology, 2011
- Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancerJournal of Ovarian Research, 2010
- Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literatureJournal of Ovarian Research, 2009
- Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancerEuropean Journal of Surgical Oncology, 2007
- CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients: From The Danish “MALOVA” Ovarian Cancer StudyGynecologic Oncology, 2007
- Change in CA 125 levels after the first cycle of induction chemotherapy is an independent predictor of epithelial ovarian tumour outcomeAnnals Of Oncology, 2007
- Significance of early changes in the serum CA-125 antigen level on overall survival in advanced ovarian cancerGynecologic Oncology, 2006
- Worldwide burden of gynaecological cancer: The size of the problemBest Practice & Research Clinical Obstetrics & Gynaecology, 2005
- Robust Locally Weighted Regression and Smoothing ScatterplotsJournal of the American Statistical Association, 1979